Academy of Physicians
in Clinical Research

Academy of Physicians
in Clinical Research

News from SCRIP

APCR Members can get a free trial to SCRIP and a discount on a SCRIP subscription by contacting John Lezcano from SCRIP directly at the information below. 

John Lezcano
Corporate Account Manager

Pharma intelligence | informa
T: (212) 652-2678
M: (631) 807-4971

ASH Preview: J&J And Legend’s CAR-T Takes Center Stage

Tue, 11/05/2019 - 11:21pm

While bluebird bio, Celgene and GSK prepare to file, it’s time to shine for another myeloma contender.

      Related Stories 

Big Pharma Advances Efforts In TB But Pricing Stays Key Concern

Tue, 11/05/2019 - 9:05pm

Price cuts, new treatments for TB and alliances to improve access to these medicines were among the key talking points...

      Related Stories 

Gene Therapy 'Vant' Unveiled As Dainippon, Roivant Finalize $3bn Deal

Tue, 11/05/2019 - 8:23pm

Japanese firm signs definitive agreement to acquire Roivant's interests in five 'vants' initially, including new gene therapy operation, as ex-Genentech...

      Related Stories 

Allergan’s Botox Gains Continue, Pipeline Progresses Ahead Of AbbVie Merger

Tue, 11/05/2019 - 2:22pm

Key Allergan drugs performed well in Q3 and pipeline programs are approaching milestones as AbbVie says its $63bn acquisition of...

      Related Stories 

Amarin's Vascepa Momentum Builds Ahead Of Next Week's FDA AdComm

Tue, 11/05/2019 - 10:57am

Sales of the triglyceride-lowering medicine soared to $112.4m in the third quarter even before a label expansion that depends on...

      Related Stories 

Theramex Buys Janssen’s Evorel Amid Ongoing HRT Shortages

Tue, 11/05/2019 - 6:19am

Amid ongoing manufacturing issues with its own HRT patches, women’s health spin-out Theramex acquires global rights to Janssen’s Evorel patches...

      Related Stories 

Turkey’s Domestic Vaccine Production Drive Prompts New Partnerships

Tue, 11/05/2019 - 2:00am

The Turkish government’s drive to establish domestic manufacturing for vaccines is showing tentative signs of getting off the ground. New...

      Related Stories 

GSK Gears Up For Three Cancer Launches In 2020

Mon, 11/04/2019 - 11:41pm

After selling off its oncology franchise just five years ago, GSK is poised to re-enter the fray - and is...

      Related Stories 

Takeda Sheds Products, Employees To Stada In $660m Move

Mon, 11/04/2019 - 10:07pm

Takeda offloads more assets as it focuses on core therapeutic areas and innovative products, this time a portfolio of products...

      Related Stories 

Jubilant Revenues Flat In Q2 On LSI Business Decline, FDA action

Mon, 11/04/2019 - 9:30pm

Jubilant reports higher second-quarter profits as it defers tax liability while revenues remain flat on the back of a decline...

      Related Stories 

Halozyme’s Spotlight Shifts To Enhanze Exclusively After PEGPH20 Fails In Phase III

Mon, 11/04/2019 - 1:56pm

The Enhanze drug delivery technology, which is expected to be profitable starting next year, takes center stage as Halozyme discontinues...

      Related Stories 

One-offs Lift Dr Reddy’s In Q2, Eyes Gx Suboxone Opportunities

Mon, 11/04/2019 - 1:49pm

One-offs aided Dr Reddy’s performance in the second quarter although US growth was flat amid challenges including the recall of...

      Related Stories 

Vifor Boosts US Nephrology Prospects With Janssen Pact

Mon, 11/04/2019 - 8:24am

Vifor has boosted its US nephrology prospects with a pact with Janssen to jointly market Invokana in diabetic kidney disease.

      Related Stories 

Pipeline Watch: Phase III Starts With Trofinetide, Gepotidacin

Mon, 11/04/2019 - 6:47am

Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events announced by pharmaceutical and biotech companies at medical...

      Related Stories 

Beyond Next Aims To Boost Bioventures Over Japan Hurdles

Sun, 11/03/2019 - 8:06pm

Set up to support the development of bioventures in Japan, Tokyo’s Beyond Next Ventures sees itself as a broad-benefit accelerator...

      Related Stories 

Theragnostics Ltd: Developing New Radiotherapies Targeted To PARP

Fri, 11/01/2019 - 2:30pm

Emerging Company Profile: The transatlantic radiopharmaceuticals start-up Theragnostics Ltd. is developing radiotherapeutics and radiodiagnostics for prostate and other cancers.

      Related Stories 

Skyrizi Launch Skyrockets, Boosting AbbVie Hopes For Humira Successors

Fri, 11/01/2019 - 2:03pm

AbbVie’s balancing act sees Skyrizi/Rinvoq launches and strong hematologic cancer strength offset the continued erosion of Humira sales outside the...

      Related Stories 

Start-Up Quarterly Statistics: Financings Continue Quarterly Declines Despite Big Venture Deals And IPOs

Fri, 11/01/2019 - 11:40am

A review of biopharma start-up dealmaking and financing activity from July through September 2019, based on data from Strategic Transactions...

      Related Stories